胰岛素帮浦市场- 分产品[设备（管式/繫绳式、无管式）、配件（电池、胰岛素储器或药筒、胰岛素套件插入装置）]、最终用途（家庭护理、医院和诊所） -全球预测，2024 年- 2032 年

Insulin Pump Market - By Product [Devices (Tubed/tethered, Tubeless), Accessories (Battery, Insulin Reservoir or Cartridges, Insulin Set Insertion Devices)], End-use (Home Care, Hospitals & Clinics) - Global Forecast, 2024 - 2032

出版日期: 2024年01月29日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在糖尿病盛行率不断上升、胰岛素帮浦设备技术进步以及人们对连续血糖监测 (CGM) 系统优势的认识不断提高的推动下，全球胰岛素帮浦市场预计 2024 年至 2032 年CAGR将达到12.4% 。

根据 IDF 预测，到 2045 年，每 8 名成年人中就有 1 人（即约 7.83 亿人）患有糖尿病，增幅达 46%。随着糖尿病成为全球流行病，对能够更好地管理和控制血糖水平的创新解决方案的需求不断增长。与传统的胰岛素注射相比，胰岛素帮浦为患者提供了更大的灵活性、精确性和便利性，从而推动了胰岛素帮浦的采用。此外，与 CGM 系统整合、改进的连接功能以及闭环系统的开发等技术进步正在进一步推动产业成长。

整个胰岛素帮浦产业根据产品、配件、最终用途和地区进行分类。

由于配件在增强胰岛素帮浦设备的功能和可用性方面的作用，预计到 2032 年配件市场将大幅成长。输液器、储液器和输注部位黏合剂等配件是确保高效率、可靠地输送胰岛素的重要组成部分。随着胰岛素帮浦疗法的采用不断增加，对相容配件的需求也增加。此外，製造商正致力于开发具有先进功能的配件，例如延长佩戴时间、提高舒适度和增强连接性，以满足患者不断变化的需求。

由于最终用途领域的医院和诊所在胰岛素帮浦疗法的采用和利用中发挥的作用，它们有望在预测期内快速成长。医院通常作为胰岛素帮浦设备和配件的通路，为患者提供教育、培训和持续的临床支援。此外，随着糖尿病盛行率的不断上升以及对先进糖尿病管理解决方案的需求不断增加，预计该细分市场将进一步成长。

在糖尿病盛行率上升、快速城市化和医疗基础设施改善的推动下，亚太地区胰岛素帮浦市场预计到 2032 年将获得成长。中国和印度等糖尿病人口众多的国家为产品的采用提供了巨大的机会。可支配收入的增加、糖尿病管理意识的提高以及政府改善医疗保健机会的倡议正在进一步推动该地区的市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 糖尿病盛行率上升
  - 胰岛素帮浦的技术进步
  - 优惠的设备保险和报销政策
- 产业陷阱与挑战
  - 胰岛素帮浦成本高
  - 严格的政府法规
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析
报销场景
未来市场趋势
缺口分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

主要趋势
装置
- 管状/繫绳
- 无内胎
配件
- 电池
- 胰岛素储液器或药筒
- 胰岛素套件插入装置

第 6 章：市场估计与预测：依最终用途，2018 年 - 2032 年

主要趋势
居家护理
医院和诊所
其他最终用户

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Debiotech S.A.
F. Hoffmann La Roche AG
Insulet Corporation
Lenomed Medical
Medtronic plc
MicroPort Scientific Corporation
Nipro Corporation
Tandem Diabetic Care Inc.
Terumo Corporation
ViCentra B.V.
Ypsomed

简介目录

Product Code: 7983

Global Insulin Pump Market is anticipated to record a CAGR of 12.4% from 2024 to 2032, driven by increasing prevalence of diabetes, technological advancements in insulin pump devices, and growing awareness about the benefits of continuous glucose monitoring (CGM) systems.

According to IDF, by 2045, projections indicate that 1 in 8 adults, or approximately 783 million people, will have diabetes, marking a 46% increase. With diabetes becoming a global epidemic, there is a growing demand for innovative solutions that offer better management and control of blood sugar levels. Insulin pumps offer patients greater flexibility, precision, and convenience in insulin delivery compared to traditional insulin injections, thus driving their adoption. Additionally, technological advancements such as integration with CGM systems, improved connectivity features, and the development of closed-loop systems are further fueling industry growth.

The overall insulin pump industry is classified based on product, accessories, end-use, and region.

Accessories segment is anticipated to grow substantially till 2032, owing to their role in enhancing the functionality and usability of insulin pump devices. Accessories such as infusion sets, reservoirs, and infusion site adhesives are essential components that ensure the efficient and reliable delivery of insulin. As the adoption of insulin pump therapy continues to rise, the demand for compatible accessories is also increasing. Moreover, manufacturers are focusing on developing accessories with advanced features such as extended wear time, improved comfort, and enhanced connectivity to meet the evolving needs of patients.

Hospitals & clinics from end-use segment is poised to grow rapidly during the forecast period, owing to their role in the adoption and utilization of insulin pump therapy. Hospitals often serve as distribution channels for insulin pump devices and accessories, providing patients with education, training, and ongoing clinical support. Moreover, with the growing prevalence of diabetes and the rising demand for advanced diabetes management solutions, further segment growth is anticipated.

Asia Pacific insulin pump market is set to gain traction till 2032, driven by increasing prevalence of diabetes, rapid urbanization, and improving healthcare infrastructure. Countries like China and India, with large diabetic populations, present significant opportunities for product adoption. Rising disposable incomes, increasing awareness about diabetes management, and government initiatives to improve healthcare access are further driving market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of diabetes
  - 3.2.1.2 Technological advancements in insulin pumps
  - 3.2.1.3 Favourable device insurance and reimbursement policies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of insulin pumps
  - 3.2.2.2 Stringent government regulations
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates And Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Devices
- 5.2.1 Tubed/tethered
- 5.2.2 Tubeless
5.3 Accessories
- 5.3.1 Battery
- 5.3.2 Insulin reservoir or cartridges
- 5.3.3 Insulin set insertion devices

Chapter 6 Market Estimates And Forecast, By End-Use, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Home care
6.3 Hospitals & clinics
6.4 Other end-users

Chapter 7 Market Estimates And Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa